Eradivir, a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads ...
Among adults with outpatient respiratory syncytial virus (RSV) infections across six RSV seasons, roughly one in 20 were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback